Advertisement

Advertisement

SG:42C Stock Latest News

Validating WaferiX and Fully Funding Wafermine: Multiple Monetisation Pathways Support Buy Rating on iX Biopharma

RatingsValidating WaferiX and Fully Funding Wafermine: Multiple Monetisation Pathways Support Buy Rating on iX Biopharma

iX Biopharma Wins US$41 Million U.S. Contract to Advance Wafermine Pain Therapy

PremiumCompany Announcements

iX Biopharma Wins US$41 Million U.S. Contract to Advance Wafermine Pain Therapy

2M ago

iX Biopharma Wins US$41 Million U.S. Defense Contract for Non-Opioid Pain Drug

PremiumCompany Announcements

iX Biopharma Wins US$41 Million U.S. Defense Contract for Non-Opioid Pain Drug

2M ago

iX Biopharma to Raise At Least S$6 Million via Share Placement

PremiumCompany Announcements

iX Biopharma to Raise At Least S$6 Million via Share Placement

2M ago

iX Biopharma Earns Third Spot on Singapore’s Fastest Growing Companies List

PremiumCompany Announcements

iX Biopharma Earns Third Spot on Singapore’s Fastest Growing Companies List

3M ago

iX Biopharma Ltd. Conducts Annual General Meeting

PremiumCompany AnnouncementsiX Biopharma Ltd. Conducts Annual General Meeting

5M ago

iX Biopharma Enters Joint Venture to Expand US Market Presence

Company Announcements

iX Biopharma Enters Joint Venture to Expand US Market Presence

5M ago

iX Biopharma Partners with Orion to Launch WaferiX® in U.S.

Company Announcements

iX Biopharma Partners with Orion to Launch WaferiX® in U.S.

5M ago

iX Biopharma Secures S$6.7 Million for U.S. Market Expansion

PremiumCompany Announcements

iX Biopharma Secures S$6.7 Million for U.S. Market Expansion

5M ago

iX Biopharma to Raise S$5 Million via Share Placement

PremiumCompany Announcements

iX Biopharma to Raise S$5 Million via Share Placement

6M ago

iX Biopharma Announces Convertible Bonds Maturity Date and Conversion Details

PremiumCompany Announcements

iX Biopharma Announces Convertible Bonds Maturity Date and Conversion Details

11M ago

iX Biopharma Ltd. Conducts Extraordinary General Meeting

PremiumCompany Announcements

iX Biopharma Ltd. Conducts Extraordinary General Meeting

1y ago

iX Biopharma Issues New Shares to Directors, Enhancing Governance

PremiumCompany AnnouncementsiX Biopharma Issues New Shares to Directors, Enhancing Governance

1y ago

iX Biopharma Proposes Appointment of BDO LLP as New Auditors

Company Announcements

iX Biopharma Proposes Appointment of BDO LLP as New Auditors

1y ago

iX Biopharma Achieves 39% Revenue Growth and Improves Operational Efficiency in 1H25

Company Announcements

iX Biopharma Achieves 39% Revenue Growth and Improves Operational Efficiency in 1H25

1y ago

iX Biopharma’s iXB 401: A Breakthrough in Drug Delivery

PremiumCompany Announcements

iX Biopharma’s iXB 401: A Breakthrough in Drug Delivery

1y ago

iX Biopharma Unveils Growth Plans at AGM

PremiumCompany Announcements

iX Biopharma Unveils Growth Plans at AGM

1y ago

iX Biopharma Ltd. Holds Key Shareholder Meeting

PremiumCompany Announcements

iX Biopharma Ltd. Holds Key Shareholder Meeting

1y ago

iX Biopharma Restructures Board Committees for Efficiency

PremiumCompany Announcements

iX Biopharma Restructures Board Committees for Efficiency

1y ago

iX Biopharma Welcomes Aging Expert to Advisory Board

PremiumCompany AnnouncementsiX Biopharma Welcomes Aging Expert to Advisory Board

1y ago

iX Biopharma Advances Global Licensing of Wafermine

Company Announcements

iX Biopharma Advances Global Licensing of Wafermine

2y ago

iX Biopharma’s New Wafer Revolutionizes NAD+ Supplementation

Company Announcements

iX Biopharma’s New Wafer Revolutionizes NAD+ Supplementation

2y ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >